Evidence map›Paper›PMID 34959705›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Mohamed A A Orabi, Heba M A Khalil, Mohamed E Abouelela, Dalia Zaafar, Yasmine H Ahmed, Reham A Naggar, Hamad S Alyami, El-Shaymaa Abdel-Sattar, Katsuyoshi Matsunami, Dalia I Hamdan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Human Lung Cancer (A549) Cell Line Cytotoxicity and Anti-Pharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Mohamed A A OrabiDepartment of Pharmacognosy, College of Pharmacy, Najran University, Najran 55461, Saudi Arabia.
Heba M A KhalilDepartment of Veterinary Hygiene and Management, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.ORCID 0000-0001-6008-2157
Mohamed E AbouelelaDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut-Branch, Assiut 71524, Egypt.ORCID 0000-0002-9489-234X
Dalia ZaafarPharmacology and Toxicology Department, Faculty of Pharmacy, Modern University for Information and Technology, Cairo 11311, Egypt.ORCID 0000-0002-7201-3658
Yasmine H AhmedCytology and Histology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
Reham A NaggarDepartment of Pharmacology and Toxicology, College of Pharmacy and Drug Manufacturing, Misr University of Science and Technology (MUST), 6th October, Giza 12566, Egypt.
Hamad S AlyamiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 55461, Saudi Arabia.ORCID 0000-0003-3513-4976
El-Shaymaa Abdel-SattarDepartment of Medical Microbiology and Immunology, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.
Katsuyoshi MatsunamiDepartment of Pharmacognosy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734-8553, Japan.ORCID 0000-0002-8034-0253
Dalia I HamdanDepartment of Pharmacognosy and Natural Products, Faculty of Pharmacy, Menoufia University, Shibin Elkom 32511, Egypt.
Cairo University · EGNajran University · SAAl-Azhar University · EGHiroshima University · JPMenoufia University · EGMisr University for Science and Technology · EGModern University for Information and Technology · EGSouth Valley University · EG

Funding

Ministry of education and the deanship of research, Najran University, Kingdom of Saudi Arabia NU/MRC/10/332
6 · The paper itself

Abstract

Chemotherapeutic-related toxicity exacerbates the increasing death rate among cancer patients, necessitating greater efforts to find a speedy solution. An in vivo assessment of the protective effect of the

Indexed as

Carissa macrocarpacytotoxicitydoxorubicinmolecular dockingneurotoxicityUPLC-ESI-MS/MS

Identifiers

PMID34959705
PMCPMC8709457
OpenAlexW4200219085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.